Biofluid infrared spectro-diagnostics: pre-analytical considerations for clinical applications.

Several proof-of-concept studies on the vibrational spectroscopy of biofluids have demonstrated that the methodology has promising potential as a clinical diagnostic tool. However, these studies also show that there is a lack of a standardised protocol in sample handling and preparation prior to spectroscopic analysis. One of the most important sources of analytical errors is the pre-analytical phase. For the technique to be translated into clinics, it is clear that a very strict protocol needs to be established for such biological samples. This study focuses on some of the aspects of the pre-analytical phase in the development of the high-throughput Fourier Transform Infrared (FTIR) spectroscopy of some of the most common biofluids such as serum, plasma and bile. Pre-analytical considerations that can impact either the samples (solvents, anti-coagulants, freeze-thaw cycles…) and/or spectroscopic analysis (sample preparation such as drying, deposit methods, volumes, substrates, operators dependence…) and consequently the quality and the reproducibility of spectral data will be discussed in this report.

[1]  M. Manfait,et al.  Diagnosis of hepatocellular carcinoma in cirrhotic patients: a proof-of-concept study using serum micro-Raman spectroscopy. , 2013, The Analyst.

[2]  O John Semmes,et al.  Analysis of Human Proteome Organization Plasma Proteome Project (HUPO PPP) reference specimens using surface enhanced laser desorption/ionization‐time of flight (SELDI‐TOF) mass spectrometry: Multi‐institution correlation of spectra and identification of biomarkers , 2005, Proteomics.

[3]  H. Abdi,et al.  Principal component analysis , 2010 .

[4]  E. Diamandis,et al.  Cancer biomarkers: can we turn recent failures into success? , 2010, Journal of the National Cancer Institute.

[5]  V. Untereiner,et al.  Bile analysis using high‐throughput FTIR spectroscopy for the diagnosis of malignant biliary strictures: a pilot study in 57 patients , 2014, Journal of biophotonics.

[6]  AbdiHervé,et al.  Principal Component Analysis , 2010, Essentials of Pattern Recognition.

[7]  L. Pusztai,et al.  Standardization efforts enabling next-generation sequencing and microarray based biomarkers for precision medicine. , 2015, Biomarkers in medicine.

[8]  H. Heise,et al.  FTIR spectroscopy of biofluids revisited: an automated approach to spectral biomarker identification. , 2013, The Analyst.

[9]  Christoph H. Borchers,et al.  The Effect of Pre-Analytical Variability on the Measurement of MRM-MS-Based Mid- to High-Abundance Plasma Protein Biomarkers and a Panel of Cytokines , 2012, PloS one.

[10]  W. Wodzig,et al.  Standardization of calibration and quality control using surface enhanced laser desorption ionization-time of flight-mass spectrometry. , 2006, Clinica chimica acta; international journal of clinical chemistry.

[11]  M. Baker,et al.  Developing and understanding biofluid vibrational spectroscopy: a critical review. , 2016, Chemical Society reviews.

[12]  Joshua D. Knowles,et al.  Procedures for large-scale metabolic profiling of serum and plasma using gas chromatography and liquid chromatography coupled to mass spectrometry , 2011, Nature Protocols.

[13]  J. Muhlestein,et al.  Potential of mid-infrared spectroscopy to aid the triage of patients with acute chest pain. , 2009, The Analyst.

[14]  E. Schleicher,et al.  The clinical chemistry laboratory: current status, problems and diagnostic prospects , 2006, Analytical and bioanalytical chemistry.

[15]  J. C. Martínez-Espinosa,et al.  Cervical cancer detection based on serum sample Raman spectroscopy , 2014, Lasers in Medical Science.

[16]  V. Untereiner,et al.  Rapid screening of classic galactosemia patients: a proof-of-concept study using high-throughput FTIR analysis of plasma. , 2015, The Analyst.

[17]  V. Untereiner,et al.  Profiling serologic biomarkers in cirrhotic patients via high-throughput Fourier transform infrared spectroscopy: toward a new diagnostic tool of hepatocellular carcinoma. , 2013, Translational research : the journal of laboratory and clinical medicine.

[18]  Alex Henderson,et al.  Assessing the challenges of Fourier transform infrared spectroscopic analysis of blood serum , 2014, Journal of biophotonics.

[19]  H. Byrne,et al.  Improved protocols for vibrational spectroscopic analysis of body fluids , 2014, Journal of biophotonics.

[20]  Michael Neumaier,et al.  Infrared spectroscopy: A new diagnostic tool in Alzheimer disease , 2007, Neuroscience Letters.

[21]  A. Fitzpatrick,et al.  Impact of Freeze-thaw Cycles and Storage Time on Plasma Samples Used in Mass Spectrometry Based Biomarker Discovery Projects , 2005, Cancer informatics.

[22]  J. H. Ward Hierarchical Grouping to Optimize an Objective Function , 1963 .

[23]  F. Martin,et al.  Vibrational spectroscopy of biofluids for disease screening or diagnosis: translation from the laboratory to a clinical setting , 2014, Journal of biophotonics.

[24]  Andreas Zell,et al.  Preanalytical aspects and sample quality assessment in metabolomics studies of human blood. , 2013, Clinical chemistry.

[25]  Rainer Lehmann,et al.  Effects of pre-analytical processes on blood samples used in metabolomics studies , 2015, Analytical and Bioanalytical Chemistry.

[26]  M Plebani,et al.  Mistakes in a stat laboratory: types and frequency. , 1997, Clinical chemistry.